Foghorn Therapeutics Inc. FHTX
2.07 USD +0.19 (+10.43%)
Nov 9, 2026, 2:49 PM EST
1.89 Day range 2.12
1.79 52-week range 7.61
- YTD
- -61.76%
- 1 year
- -52.64%
FHTX revenue history
Revenue is income from the company’s ordinary business activities.
30,909,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 30,909,000 | 8,307,000 | 36.75% |
| FY 2024 | 2024-12-31 | 22,602,000 | -11,553,000 | -33.83% |
| FY 2023 | 2023-12-31 | 34,155,000 | 14,927,000 | 77.63% |
| FY 2022 | 2022-12-31 | 19,228,000 | 17,909,000 | 1357.77% |
| FY 2021 | 2021-12-31 | 1,319,000 | 889,000 | 206.74% |
| FY 2020 | 2020-12-31 | 430,000 | 430,000 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:48.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.